Antiepileptic drugs in migraine prophylaxis: State of the art

A. Capuano, C. Vollono, Daniele Mei, L. Pierguidi, D. Ferraro, G. Di Trapani

Research output: Contribution to journalArticle

Abstract

Antiepileptic drugs have proven their efficacy in the prophylactic treatment of migraine. Our study comprises a clinical trial that examines the efficacy of gabapentin and topiramate and a description of the pharmacologic characteristics and the efficacy of tiagabine, lamotrigine, levetiracetam and zonisamide. Antiepileptic drugs have multiple modes of action which can explain their efficacy in reducing neuronal excitability which is proven in epilepsy and postulated in migraine. The relationship between epilepsy and migraine has, in fact, been much debated but never convincingly proven. Antiepileptic drugs coud be useful in migraine prophylaxis as some of these have determined a reduction in the monthly frequency and intensity of crises in subjects suffering from migraine with and without aura. These are the aims that have been proposed by the U.S. Headache Consortium Evidence-Based Guidelines. Further double-blind placebo-controlled studies are necessary in order to assess their safety and efficacy.

Original languageEnglish
Pages (from-to)79-87
Number of pages9
JournalClinica Terapeutica
Volume155
Issue number2-3
Publication statusPublished - Feb 2004

Fingerprint

Migraine Disorders
Anticonvulsants
etiracetam
zonisamide
Epilepsy
Migraine without Aura
Migraine with Aura
Headache
Placebos
Clinical Trials
Guidelines
Safety
Therapeutics

Keywords

  • Migraine
  • Therapy and antiepilectic drugs

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Capuano, A., Vollono, C., Mei, D., Pierguidi, L., Ferraro, D., & Di Trapani, G. (2004). Antiepileptic drugs in migraine prophylaxis: State of the art. Clinica Terapeutica, 155(2-3), 79-87.

Antiepileptic drugs in migraine prophylaxis : State of the art. / Capuano, A.; Vollono, C.; Mei, Daniele; Pierguidi, L.; Ferraro, D.; Di Trapani, G.

In: Clinica Terapeutica, Vol. 155, No. 2-3, 02.2004, p. 79-87.

Research output: Contribution to journalArticle

Capuano, A, Vollono, C, Mei, D, Pierguidi, L, Ferraro, D & Di Trapani, G 2004, 'Antiepileptic drugs in migraine prophylaxis: State of the art', Clinica Terapeutica, vol. 155, no. 2-3, pp. 79-87.
Capuano A, Vollono C, Mei D, Pierguidi L, Ferraro D, Di Trapani G. Antiepileptic drugs in migraine prophylaxis: State of the art. Clinica Terapeutica. 2004 Feb;155(2-3):79-87.
Capuano, A. ; Vollono, C. ; Mei, Daniele ; Pierguidi, L. ; Ferraro, D. ; Di Trapani, G. / Antiepileptic drugs in migraine prophylaxis : State of the art. In: Clinica Terapeutica. 2004 ; Vol. 155, No. 2-3. pp. 79-87.
@article{09ce4b653c854998bef7c3922e1586a1,
title = "Antiepileptic drugs in migraine prophylaxis: State of the art",
abstract = "Antiepileptic drugs have proven their efficacy in the prophylactic treatment of migraine. Our study comprises a clinical trial that examines the efficacy of gabapentin and topiramate and a description of the pharmacologic characteristics and the efficacy of tiagabine, lamotrigine, levetiracetam and zonisamide. Antiepileptic drugs have multiple modes of action which can explain their efficacy in reducing neuronal excitability which is proven in epilepsy and postulated in migraine. The relationship between epilepsy and migraine has, in fact, been much debated but never convincingly proven. Antiepileptic drugs coud be useful in migraine prophylaxis as some of these have determined a reduction in the monthly frequency and intensity of crises in subjects suffering from migraine with and without aura. These are the aims that have been proposed by the U.S. Headache Consortium Evidence-Based Guidelines. Further double-blind placebo-controlled studies are necessary in order to assess their safety and efficacy.",
keywords = "Migraine, Therapy and antiepilectic drugs",
author = "A. Capuano and C. Vollono and Daniele Mei and L. Pierguidi and D. Ferraro and {Di Trapani}, G.",
year = "2004",
month = "2",
language = "English",
volume = "155",
pages = "79--87",
journal = "Clinica Terapeutica",
issn = "0009-9074",
publisher = "Societa Editrice Universo",
number = "2-3",

}

TY - JOUR

T1 - Antiepileptic drugs in migraine prophylaxis

T2 - State of the art

AU - Capuano, A.

AU - Vollono, C.

AU - Mei, Daniele

AU - Pierguidi, L.

AU - Ferraro, D.

AU - Di Trapani, G.

PY - 2004/2

Y1 - 2004/2

N2 - Antiepileptic drugs have proven their efficacy in the prophylactic treatment of migraine. Our study comprises a clinical trial that examines the efficacy of gabapentin and topiramate and a description of the pharmacologic characteristics and the efficacy of tiagabine, lamotrigine, levetiracetam and zonisamide. Antiepileptic drugs have multiple modes of action which can explain their efficacy in reducing neuronal excitability which is proven in epilepsy and postulated in migraine. The relationship between epilepsy and migraine has, in fact, been much debated but never convincingly proven. Antiepileptic drugs coud be useful in migraine prophylaxis as some of these have determined a reduction in the monthly frequency and intensity of crises in subjects suffering from migraine with and without aura. These are the aims that have been proposed by the U.S. Headache Consortium Evidence-Based Guidelines. Further double-blind placebo-controlled studies are necessary in order to assess their safety and efficacy.

AB - Antiepileptic drugs have proven their efficacy in the prophylactic treatment of migraine. Our study comprises a clinical trial that examines the efficacy of gabapentin and topiramate and a description of the pharmacologic characteristics and the efficacy of tiagabine, lamotrigine, levetiracetam and zonisamide. Antiepileptic drugs have multiple modes of action which can explain their efficacy in reducing neuronal excitability which is proven in epilepsy and postulated in migraine. The relationship between epilepsy and migraine has, in fact, been much debated but never convincingly proven. Antiepileptic drugs coud be useful in migraine prophylaxis as some of these have determined a reduction in the monthly frequency and intensity of crises in subjects suffering from migraine with and without aura. These are the aims that have been proposed by the U.S. Headache Consortium Evidence-Based Guidelines. Further double-blind placebo-controlled studies are necessary in order to assess their safety and efficacy.

KW - Migraine

KW - Therapy and antiepilectic drugs

UR - http://www.scopus.com/inward/record.url?scp=3543045566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543045566&partnerID=8YFLogxK

M3 - Article

C2 - 15244112

AN - SCOPUS:3543045566

VL - 155

SP - 79

EP - 87

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 2-3

ER -